Eric J. Loumeau - 14 Sep 2023 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role: Chief Legal Officer
Signature: /s/ Eric Loumeau
Issuer symbol: ANAB
Transactions as of: 14 Sep 2023
Net transactions value: -$116,238
Form type: 4
Filing time: 18 Sep 2023, 18:13:51 UTC
Previous filing: 10 Jan 2023
Next filing: 27 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANAB	Common Stock	Options Exercise		+6,000	+680%		6,882	14 Sep 2023	Direct	F1, F2
transaction	ANAB	Common Stock	Sale	$41,005	-2,105	-31%	$19.48	4,777	14 Sep 2023	Direct	F3
transaction	ANAB	Common Stock	Sale	$75,232	-3,895	-82%	$19.32	882	18 Sep 2023	Direct	F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANAB	Restricted Stock Unit	Options Exercise	$0	-6,000	-50%	$0.000000	6,000	14 Sep 2023	Common Stock	6,000		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2	Reflects the acquisition of 882 shares acquired under the Company's ESPP.
F3	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F4	The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.135 to $19.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F6	50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.